Global Immunoglobulin Products Market Growth 2023-2029

Global Immunoglobulin Products Market Growth 2023-2029

Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen. These are made up of basic structural unit’s namely heavy chains and light chains. In mammals five different types of antibodies (IgA, IgD, IgE, IgG and IgM) are present which perform different role in response to the type of foreign antibody encountered. Occurrences of situations where people are born with low or no level of immunoglobulin, or with an immune system that does not function properly are very common. In such condition fighting with germs and other infections become extremely difficult. Therefore, immunoglobulin therapy plays an important role for compensating the insufficient quantity of immunoglobulin in the body.

LPI (LP Information)' newest research report, the “Immunoglobulin Products Industry Forecast” looks at past sales and reviews total world Immunoglobulin Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunoglobulin Products sales for 2023 through 2029. With Immunoglobulin Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunoglobulin Products industry.

This Insight Report provides a comprehensive analysis of the global Immunoglobulin Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunoglobulin Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immunoglobulin Products market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunoglobulin Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunoglobulin Products.

The global Immunoglobulin Products market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The recent approval of immunoglobulins to treat neuroimmunological disorders is a noteworthy factor that will impel the prospects for market growth until the end of the forecast period. Recently, immunoglobulin products were approved for the treatment of neuroimmunological disorders like multifocal motor neuropathy, Alzheimer's disease, and Guillain-Barré syndrome. Due to its widespread applicability, immunoglobulin products that are utilized for the treatment of neuroimmunological disorders are anticipated to contribute the largest proportion of revenue to the global immunoglobulin products market in the next few years. Immunoglobulin products used for the treatment of primary immunodeficiency disease (PID) and neuroimmunological disorders account for around 80% of the total market revenue.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunoglobulin Products market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
IG A
IG G
IG M
IG D
IG E

Segmentation by application
CIDP
Immunodeficiency Diseases
ITP
Hypogammaglobulinemia
Congenital AIDS
Multifocal Motor Neuropathy
CLL
Myasthenia Gravis
Kawasaki Disease

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
China Biologic Products
Grifols
Biotest Pharmaceuticals
Bio Products Laboratory
Octapharma
CSL
Kedrion
Bharat Serums and Vaccines
Emergent Biosolutions

Key Questions Addressed in this Report

What is the 10-year outlook for the global Immunoglobulin Products market?

What factors are driving Immunoglobulin Products market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Immunoglobulin Products market opportunities vary by end market size?

How does Immunoglobulin Products break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.